SF3B1 and neoplasm: e.g., if cytogenetic, genetic or epigenetic changes associated with a more favorable prognosis such as disomy 3, or mutations in EIF1AX or SF3B1 are relatively more common in the north -even though tumor dimensions are similar [22, 27–30].